Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
49.55%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth49.55%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
4.0
8.47%
60%
—
-100.00%
20%
—
5 Years
Score4.0
Net Growth8.47%
Net Trend60%
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
Cocrystal Pharma Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 2M to $ 0.00 and net income went from -$ 9M to -$ 8M. Revenue increased in 1 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 78K to $ 0.00 and net income went from -$ 50M to -$ 8M. Revenue increased in 2 of those 10 years; net income in 6.
Cocrystal Pharma Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.12 | — |
1 Year2025-08-12 | $ 1.65 | -32.12% |
5 Years2021-08-12 | $ 12.84 | -91.28% |
10 Years2016-08-12 | $ 162.00 | -99.31% |
All Time2011-05-19 | $ 5.50 | -79.64% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2011-05-19 |
|---|---|---|---|---|---|
| Price | $ 1.12 | $ 1.65 | $ 12.84 | $ 162.00 | $ 5.50 |
| Return | — | -32.12% | -91.28% | -99.31% | -79.64% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 8M | $ 7M |
| 2024 | $ 0.00 | -$ 17M | $ 9M |
| 2023 | $ 0.00 | -$ 17M | $ 26M |
| 2022 | $ 0.00 | -$ 38M | $ 37M |
| 2021 | $ 5M | -$ 14M | $ 58M |
| 2020 | $ 2M | -$ 9M | $ 33M |
| 2019 | $ 6M | -$ 48M | $ 7M |
| 2018 | $ 0.00 | -$ 49M | $ 2M |
| 2017 | $ 0.00 | -$ 613K | $ 748K |
| 2016 | $ 0.00 | -$ 74M | $ 3M |
| 2015 | $ 78K | -$ 50M | $ 9M |
| 2014 | $ 9K | -$ 99K | $ 5M |
| 2013 | -$ 19M | $ 589.47K | |
| 2012 | $ 17M | -$ 7M | $ 62.3K |
| IPO2011 | $ 12M | -$ 5M | $ 416.33K |
Explore beyond COCP
You're looking at Cocrystal Pharma Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
